Pharmaceuticals
Prisons fight opioids with $1,000 injection: Does it work? | STATUS prisons are experimenting with a high-priced monthly injection that could help addicted inmates stay off opioids after they are released, but skeptics question its effectiveness and say the manufacturer has aggressively marketed an unproven drug to corrections officials.
Studies Show Little Benefit in Supplements | The New York Times
Americans spend more than $30 billion a year on dietary supplements — vitamins, minerals and herbal products, among others — many of which are unnecessary or of doubtful benefit to those taking them.
Medical devices
German medical device maker Carl Zeiss scouting takeover targets | ReutersGermany's Carl Zeiss, a maker of optical systems and medical devices, is scouring the market for targeted takeovers to boost the group's expansion, Chief Executive Michael Kaschke told Welt am Sonntag.
Physicians
Few doctors sign on to recommend medical marijuana in Maryland | The Baltimore SunJust 1 percent of the 16,000 doctors who treat patients in Maryland have signed up for the state's medical marijuana program, and two of the largest hospital systems in the state have banned their physicians from participating. The lack of enthusiasm threatens to undermine the fledgling program by limiting access to the drug that has shown promise in easing pain and other severe conditions.
Safety, quality and clinical practice
Community Paramedics Work To Link Patients With Mental Health Care | Kaiser Health NewsAfter a physical assessment, paramedics like Kjelstrom talk to the patient — to figure out what, precisely, the issue is, asking also about issues like a patient's mental health history, drug use and insurance status. They use that information, along with details about resources available, to figure out the next steps for the patient — maybe it is a hospital or a psych facility, or maybe it is outpatient care.
